Corcept Therapeutics Incorporated
Price Action
Technical Summary
WEAKENINGCorcept Therapeutics Incorporated is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings contraction of 276% provides fundamental context to the price action. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $46.78 | +9.13% | ABOVE |
| 50 SMA | $40.58 | +25.80% | ABOVE |
| 100 SMA | $44.90 | +13.70% | ABOVE |
| 150 SMA | $56.07 | -8.95% | BELOW |
| 200 SMA | $60.31 | -15.36% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CORT in an uptrend right now?
CORT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CORT overbought or oversold?
CORT's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is CORT outperforming the market?
CORT has a Relative Strength (RS) Rating of 46 out of 99. CORT is currently lagging the broader market.
Where is CORT in its 52-week range?
CORT is trading at $51.05, which is 56% of its 52-week high ($91.00) and 36% above its 52-week low ($28.66).
How volatile is CORT?
CORT has a Beta of 1.78 and 52-week volatility of 75%. It's more volatile than the S&P 500 - expect bigger swings.